Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-03 Sale | 2022-06-07 4:03 pm | Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director | 4,567 | $0.362 | $1,653 | 43,430 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:25 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO | 79,026 | $2.1657 | $171,143 | 2,462,803 (Indirect Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:12 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP Chief Medical Officer | 15,056 | $2.1629 | $32,564 | 442,663 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:12 pm | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta CAO | 3,946 | $2.1548 | $8,503 | 139,954 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:11 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP Chief Operating Officer | 21,533 | $2.1659 | $46,637 | 497,017 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:10 pm | Akebia Therapeutics Inc. | AKBA | Faulkingham Dell VP | 13,184 | $2.1629 | $28,515 | 373,841 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:10 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP Chief Legal Officer | 21,062 | $2.1658 | $45,615 | 504,241 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:09 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A CFO | 8,203 | $2.1564 | $17,689 | 353,599 (Direct) | View |
| 2022-01-03 Sale | 2022-01-05 4:11 pm | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta CAO | 5,833 | $2.2862 | $13,335 | 33,067 (Direct) | View |
| 2021-08-31 Sale | 2021-09-02 4:07 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP Chief Medical Officer | 1,042 | $2.83 | $2,949 | 171,219 (Direct) | View |
| 2021-06-07 Sale | 2021-06-09 4:26 pm | Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director | 4,567 | $3.3202 | $15,163 | 47,997 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:35 pm | Akebia Therapeutics Inc. | AKBA | Faulkingham Dell VP | 952 | $3.4 | $3,237 | 137,025 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:34 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A CFO | 790 | $3.4 | $2,686 | 76,802 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:33 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP Chief Legal Officer | 1,060 | $3.4 | $3,604 | 272,303 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:33 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP Chief Operating Officer | 1,211 | $3.4 | $4,117 | 265,550 (Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:32 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO | 4,109 | $3.4 | $13,971 | 1,534,103 (Indirect Direct) | View |
| 2021-04-01 Sale | 2021-04-01 8:31 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP Chief Medical Officer | 1,081 | $3.4 | $3,675 | 170,761 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-08 Option Award | 2022-06-10 08:11 am | 2023-05-12 2032-06-08 | Akebia Therapeutics Inc. | AKBA | Spellman David A CFO | 200,000 | $0 | 528,599 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:01 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director | 33,800 | $0 | 33,800 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:00 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 33,800 | $0 | 57,781 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:59 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director | 33,800 | $0 | 85,333 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:58 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director | 33,800 | $0 | 86,129 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:58 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director | 33,800 | $0 | 77,230 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:57 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | FRIESON RON Director | 33,800 | $0 | 33,800 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:56 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 33,800 | $0 | 124,900 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 4:08 pm | 2023-05-12 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP Chief Medical Officer | 200,000 | $0 | 617,663 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 4:04 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta CAO | 150,000 | $0 | 219,954 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:25 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO | 1,032,825 | $0 | 2,462,803 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:12 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP Chief Medical Officer | 285,000 | $0 | 442,663 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:12 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Cotreau Violetta CAO | 110,833 | $0 | 139,954 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:11 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP Chief Operating Officer | 250,000 | $0 | 497,017 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:10 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Faulkingham Dell VP | 250,000 | $0 | 373,841 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:10 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP Chief Legal Officer | 250,000 | $0 | 504,241 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:09 pm | N/A 2032-02-28 | Akebia Therapeutics Inc. | AKBA | Spellman David A CFO | 285,000 | $0 | 353,599 (Direct) | View |
| 2018-12-12(A) Other | 2022-02-18 9:55 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO | 1,248 | $0 | 377,113 (Direct) | View |
| 2021-11-01 Option Award | 2021-11-03 4:47 pm | N/A 2031-11-01 | Akebia Therapeutics Inc. | AKBA | FRIESON RON Director | 80,200 | $0 | 80,200 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-01 4:06 pm | N/A 2031-09-30 | Akebia Therapeutics Inc. | AKBA | Spellman David A CFO | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-03 5:28 pm | 2022-06-02 2031-06-02 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 33,800 | $0 | 44,081 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-03 5:27 pm | 2022-06-02 2031-06-02 | Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director | 33,800 | $0 | 71,633 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-03 5:27 pm | 2022-06-02 2031-06-02 | Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director | 33,800 | $0 | 72,429 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-03 5:27 pm | 2022-06-02 2031-06-02 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 33,800 | $0 | 111,200 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-03 5:27 pm | 2022-06-02 2031-06-02 | Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director | 33,800 | $0 | 68,686 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-03 5:26 pm | 2022-06-02 2031-06-02 | Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director | 33,800 | $0 | 72,664 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:19 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Spellman David A CFO | 7,592 | $0 | 77,592 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:18 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO | 9,152 | $0 | 137,977 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:18 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP Chief Legal Officer | 10,192 | $0 | 273,363 (Direct) | View |